Literature DB >> 33764325

Mean Platelet Volume, Association with Inflammatory and Nutritional Markers in Maintenance Hemodialysis Patients.

Omolbanin Taziki, Tayebeh Mohammad Alizadeh, Toktam Alirezaei1.   

Abstract

INTRODUCTION: Mean Platelet Volume (MPV) has been revealed to be a risk factor for ischemic heart disease in the hemodialysis patients .The aim of present study is to investigate the association between MPV level with inflammatory and nutritional factors in patients requiring chronic hemodialysis.
METHODS: 100 patients who were on maintenance hemodialysis were included. Based on the median MPV (8.7 fL) patients were divided into two groups of low and high MPV level to assess and compare in terms of inflammatory (erythrocyte sedimentation rate, C-reactive protein, and transferrin), and nutritional (albumin, ferritin, uric acid, blood urea nitrogen, creatinine, triglyceride, cholesterol, low density lipoprotein, and high density lipoprotein) parameters.
RESULTS: The median MPV level in our patients was 8.7 ± 1.8 fl. There was no statistical difference in the level of inflammatory and nutritional markers between the two groups, and none of them were related to MPV level (P > .05). The prevalence of IHD was significantly higher in the high MPV group (P < .05). After adjustment for the age, no association was observed between different parameters and MPV level except for transferrin in patient's ≤ 60 years old. Mean transferrin levels were significantly lower in the high MPV group (P < .05).
CONCLUSION: Present study did not show any association between inflammatory and nutritional markers with MPV level in hemodialysis patients except for the transferrin level in younger cases.

Entities:  

Year:  2021        PMID: 33764325

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  2 in total

1.  The Relationship between Sleep Quality and Hemodialysis and Nursing Intervention in Uremia Patients Based on Intelligent Data.

Authors:  Aixia Lin; Fujuan Zhang; Huifang Zhang
Journal:  Biomed Res Int       Date:  2022-07-25       Impact factor: 3.246

2.  Significant decrease in plasmad-dimer levels and mean platelet volume after a 3-month treatment with rosuvastatin in patients with venous thromboembolism.

Authors:  Toktam Alirezaei; Haniyeh Sattari; Rana Irilouzadian
Journal:  Clin Cardiol       Date:  2022-04-28       Impact factor: 3.287

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.